Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Case Reports in Neurological Medicine|August 16, 2016
Advanced Genetic Testing Comes to the Pain Clinic to Make a Diagnosis of Paroxysmal Extreme Pain DisorderAshley Cannon, Svetlana Kurklinsky, Kimberly J Guthrie, et al.Journal of Genetic Counseling|May 14, 2025
Family history does not influence stress or major coping styles in adults with neurofibromatosis type 1Mikaela Bradley, Ashley Cannon, Bryce Brown, et al.Plos One|January 28, 2014
Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modelingSimon D'Alton, Marcelle Altshuler, Ashley Cannon, et al.The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|April 27, 2018
Engaging Stakeholders in the Development of an eHealth Intervention for Cancer Symptom Management for Rural ResidentsStephanie Gilbertson-White, Chi W Yeung, Seyedehtanaz Saeidzadeh, et al.Journal of Genetic Counseling|May 15, 2023
Parent perspectives on disclosing a pediatric neurofibromatosis type 1 diagnosisMadeleine Franchi, Heather B Radtke, Andrea M Lewis, et al.Journal of Genetic Counseling|July 1, 2020
Genetic Counseling for Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis-Practice Resource of the National Society of Genetic CounselorsHeather B Radtke, Amanda L Bergner, Allison L Goetsch, et al.Neuro-Oncology Practice|March 9, 2026
Neurogenetic tumor syndromes: The current landscape of workup and treatmentRimas V Lukas, Ashley Cannon, Prashant Chittiboina, et al.Prenatal Diagnosis|February 15, 2025
Cell-Free DNA Results Indicating Mosaic Monosomy X of Likely Maternal Origin: Impact on Genetic Counseling Practices and Patient ExperiencesAudrey McBride, Ashley Cannon, Siddharth Prakash, et al.Orphanet Journal of Rare Diseases|February 9, 2018
Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history studyAshley Cannon, Mei-Jan Chen, Peng Li, et al.Journal of Psychiatric Research|December 21, 2021
Blocking the orexin system following therapeutic exposure promoted between session habituation, but not PTSD symptom reductionIhori Kobayashi, Thomas A Mellman, Ashley Cannon, et al.Pageof 5